Cardiff Oncology (CRDF)
(Delayed Data from NSDQ)
$4.07 USD
+0.08 (2.01%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.20 +0.13 (3.19%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, Cardiff Oncology (CRDF) reported earnings of -$0.21 per share, beating the Zacks Consensus Estimate of $-0.26 per share. This reflects a positive earnings surprise of 19.23%. Look out for CRDF's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for CRDF
Cardiff (CRDF) Stock Rallies 194% in a Month: Here's Why
CRDF: What are Zacks experts saying now?
Zacks Private Portfolio Services